NZ728239A - Immune motifs in products from domestic animals - Google Patents

Immune motifs in products from domestic animals

Info

Publication number
NZ728239A
NZ728239A NZ728239A NZ72823915A NZ728239A NZ 728239 A NZ728239 A NZ 728239A NZ 728239 A NZ728239 A NZ 728239A NZ 72823915 A NZ72823915 A NZ 72823915A NZ 728239 A NZ728239 A NZ 728239A
Authority
NZ
New Zealand
Prior art keywords
immune
motifs
products
product
domestic animals
Prior art date
Application number
NZ728239A
Other languages
English (en)
Inventor
Robert D Bremel
Jane Homan
Original Assignee
Iogenetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iogenetics Llc filed Critical Iogenetics Llc
Publication of NZ728239A publication Critical patent/NZ728239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NZ728239A 2014-07-11 2015-07-10 Immune motifs in products from domestic animals NZ728239A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462023220P 2014-07-11 2014-07-11
US201562138460P 2015-03-26 2015-03-26
PCT/US2015/039970 WO2016007871A2 (fr) 2014-07-11 2015-07-10 Motifs immunitaires dans des produits issus d'animaux domestiques

Publications (1)

Publication Number Publication Date
NZ728239A true NZ728239A (en) 2018-08-31

Family

ID=55065098

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ728239A NZ728239A (en) 2014-07-11 2015-07-10 Immune motifs in products from domestic animals

Country Status (5)

Country Link
US (2) US10799582B2 (fr)
EP (1) EP3166631B1 (fr)
AU (3) AU2015287622B2 (fr)
NZ (1) NZ728239A (fr)
WO (1) WO2016007871A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210265008A1 (en) * 2018-05-10 2021-08-26 Iogenetics, Llc Immune repertoire patterns
US20240016887A1 (en) * 2020-12-07 2024-01-18 Iogenetics, Llc Bystander protein vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
EP4012714A1 (fr) 2010-03-23 2022-06-15 Iogenetics, LLC. Procédés bioinformatiques pour déterminer la liaison de peptides
EP2771349B1 (fr) 2011-09-16 2020-02-26 Iogenetics, LLC. Procédés bio-informatiques de détermination de liaisons peptidiques
JP2014011083A (ja) 2012-06-29 2014-01-20 Canon Inc 有機ｅｌ表示装置の製造方法
EP2684986B1 (fr) 2012-07-12 2016-11-02 Thomas GmbH Procédé d'oxydation électrolytique de surfaces sur des corps creux métalliques
US11069427B2 (en) 2013-06-10 2021-07-20 Iogenetics, Llc Mathematical processes for determination of peptidase cleavage

Also Published As

Publication number Publication date
US10799582B2 (en) 2020-10-13
US20180221474A1 (en) 2018-08-09
WO2016007871A2 (fr) 2016-01-14
EP3166631A2 (fr) 2017-05-17
AU2021200558B2 (en) 2023-03-09
AU2019200707A1 (en) 2019-02-21
AU2021200558A1 (en) 2021-03-04
AU2015287622A1 (en) 2017-02-02
EP3166631C0 (fr) 2023-09-06
WO2016007871A3 (fr) 2016-03-10
EP3166631A4 (fr) 2018-03-21
AU2015287622B2 (en) 2018-11-01
EP3166631B1 (fr) 2023-09-06
US20210023212A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
PH12017501342A1 (en) Glycan therapeutics and related methods thereof
WO2017134302A3 (fr) Agents thérapeutiques ciblés et leurs utilisations
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
Sarbatova et al. Developing a specialized meat product based on ostrich
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
EP3243517A4 (fr) Composition médicinale, dispositif de traitement de sang, produit cosmétique, aliment et boisson utilisant une matière de synthèse de combustion
MX2017015702A (es) Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.
NZ735362A (en) Lipid compositions
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
MX2017005756A (es) Producto alimenticio para mascotas extruido.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
BR112017022523A2 (pt) ?formulação para cápsulas de gel, cápsula de gel, e, processo?.
NZ728239A (en) Immune motifs in products from domestic animals
ITUB20160487A1 (it) Apparato di trattamento di prodotti ortofrutticoli.
PH12018550097A1 (en) Infant formula comprising human milk peptides
IT201700094800A1 (it) Impianto per la produzione di contenitori, particolarmente contenitori per prodotti medicali, farmaceutici, cosmetici, alimentari o simili
PH12016501947B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
IL270936A (en) A factor, food and drug that improve brain activity through lipopolysaccharide
MX2018004796A (es) Conservacion de vitaminas hidrosolubles.
EP3441076A4 (fr) Produit pharmaceutique destiné au traitement d'une tumeur et d'un défaut immunitaire combiné, préparation et application de ce dernier
PH12016501205A1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
PL3319621T3 (pl) Kompozycje oraz sposoby modulowania i/lub stymulowania odpowiedzi immunologicznych u człowieka i/lub zwierzęcia
PH12018500165A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUL 2020 BY COMPUTER PACKAGES INC

Effective date: 20190618

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUL 2021 BY COMPUTER PACKAGES INC

Effective date: 20200618

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUL 2022 BY COMPUTER PACKAGES INC

Effective date: 20210617

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUL 2023 BY COMPUTER PACKAGES INC

Effective date: 20220618

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUL 2024 BY COMPUTER PACKAGES INC

Effective date: 20230617